CVE-2026-32921OpenClaw before 2026.3.8 contains an approval bypass vulnerability in system.run where mutable script operands are not bound across approval and execution phases.
Updated under an hour ago ()
Does this affect you?
It affects openclaw. Add what you run to find out whether that includes you.
No exploitation reported and no EPSS estimate yet.
Do this next
Free account, 1 product
OpenClaw before 2026.3.8 contains an approval bypass vulnerability in system.run where mutable script operands are not bound across approval and execution phases. Attackers can obtain approval for script execution, modify the approved script file before execution, and execute different content while maintaining the same approved command shape.
- CVSS
- 5.0 MEDIUM (v3.1, NVD)CVSS:3.1/AV:N/AC:H/PR:L/UI:N/S:U/C:L/I:L/A:L
- Weakness (CWE)
- CWE-367
- Known exploited
- Not in CISA's KEV catalog
- EPSS (exploitation in the next 30 days)
- Not loaded for this CVE
- Assigned by
- Not given
- NVD analysis
- Analyzed
- Record last updated
- Jul 25, 2026
- First seen by InfoSec Signals
- Oct 9, 2026
Affected products
openclaw openclaw openclaw:openclaw | before 2026.3.8 | NVD |
References
- https://github.com/openclaw/openclaw/commit/c76d29208bf6a7f058d2cf582519d28069e42240patch
- https://github.com/openclaw/openclaw/commit/cf3a479bd1204f62eef7dd82b4aa328749ae6c91patch
- https://github.com/openclaw/openclaw/security/advisories/GHSA-8g75-q649-6pv6vendor-advisory
- https://www.vulncheck.com/advisories/openclaw-script-content-modification-via-mutable-operand-binding-in-system-runthird-party-advisory
The CVE record on cve.org NVD's entry
The CVE record is authoritative. Products marked “from the name” were identified from the CNA's free-text names, not a CPE, and are matched less certainly. This product uses the NVD API but is not endorsed or certified by the NVD.